Skip to content
Open access

A heterogeneous multimodal ensemble framework for multi-omics breast cancer prognosis

Aug 2026 · Clinical Cancer Bulletin · Vol 5 · 0 citations · 61 references

TL;DR

It is demonstrated that assigning complementary roles to stacking multimodal information integration and bagging for prediction stabilization provides an effective and robust framework for multi-omics breast cancer prognosis, supporting the use of complementary ensemble paradigms for multimodal prediction in precision oncology.

Abstract

Accurate breast cancer prognosis remains a major challenge in precision oncology due to tumor heterogeneity and the complexity of integrating high-dimensional multi-omics data. Although multimodal learning approaches have improved predictive performance by combining clinical and molecular information, many existing methods rely on a single ensemble strategy that remains susceptible to prediction variance and limited robustness in high-dimensional, low-sample-size biomedical datasets. This study investigated whether integrating complementary ensemble strategies within a unified multimodal framework could improve the robustness and predictive performance of breast cancer prognosis. A heterogeneous multimodal ensemble framework was developed in which stacking was used to integrate complementary information from clinical, gene expression, and copy number variation (CNV) data through meta-learning, while bagging was incorporated to stabilize the meta-learning process via bootstrap aggregation. The outputs of the stacking and bagging branches were combined using weighted probability fusion. The framework was evaluated on the METABRIC breast cancer cohort and compared with unimodal models and a conventional stacking ensemble using an independent test set and stratified tenfold cross-validation. The proposed hybrid framework achieved a ROC-AUC of 0.936, outperforming unimodal clinical and molecular models (ROC-AUC = 0.8140.885) and the conventional stacking ensemble (ROC-AUC = 0.898). Stratified tenfold cross-validation further demonstrated consistent improvements in mean ROC-AUC, recall, F1-score, balanced accuracy, and Matthews correlation coefficient, indicating improved robustness and stable performance across the internal validation folds. On the independent test set, the hybrid framework reduced false-negative predictions and increased sensitivity relative to the stacking ensemble, demonstrating a more favorable balance between identifying high-risk patients and maintaining overall predictive performance. Rather than introducing a new ensemble algorithm, this study demonstrates that assigning complementary roles to stacking multimodal information integration and bagging for prediction stabilization provides an effective and robust framework for multi-omics breast cancer prognosis. The proposed hybrid strategy consistently improved predictive performance and robustness compared with conventional stacking while demonstrating stable performance across internal validation, supporting the use of complementary ensemble paradigms for multimodal prediction in precision oncology.

Read PDF

Similar papers

Open access Aug 2026

Identifying multi-omics biomarkers for ovarian cancer survival estimation

An interpretable three-stage machine learning framework integrating mRNA, microRNA, DNA methylation, copy number variation, and protein expression data from The Cancer Genome Atlas that couples improved prognostic estimation with biological interpretability supporting multi-omics biomarker discovery in ovarian cancer.

Kosar Fateh, S. Sathipati · 0 citations
Open access Oct 2026

Cervical cancer survival analysis by integrating multi-omics data through an adaptive weighted deep neural network.

Accurately analyzing cervical cancer prognosis holds significant importance for enhancing clinical outcomes within the framework of precision medicine. Since single-omics data only capture a limited perspective of cervical cancer patients, integrating multiple types of omics data is essential to provide more comprehens...

Jin-Yong Zheng, Zi-Yao Su, Xiao-Hui Zhuo et al. · 0 citations
Review Open access Sep 2026

AI-driven multi-omics integration in breast cancer: clinical applications, immunotherapy prediction, and translational challenges

Overall, AI-driven multi-omics strategies offer a promising framework for improving individualized treatment selection and real-time monitoring in breast cancer, although robust prospective validation and multidisciplinary implementation are still required before routine clinical adoption.

Zi-Yao Wang, Na Liu, Min-Bin Chen · 0 citations
Open access Sep 2026

UMPM-Net: A Multimodal Deep Learning Framework for Colorectal Cancer Prognosis

The proposed UMPM-Net is a comprehensive, explainable and robust multimodal learning framework that is capable of accurate, interpretable, and clinically relevant prognostication for colorectal cancer.

K. Muthuchamy, S. K. Piramu Preethika · 0 citations
Review Open access Sep 2026

AI-driven multi-omics biomarkers in precision breast cancer therapeutics: from discovery to clinical translation

Breast cancer is biologically heterogeneous, yet conventional clinical decisions rely on static, single-marker proxies (ER, PR, HER2, and Ki-67) that capture only a narrow slice of tumor biology. This mini-review argues that AI-driven multi-omics biomarkers offer a valuable shift toward systems-level, model-derived pro...

D. Stylianakis, R. Sánchez-Bayona, N. Denaro et al. · 0 citations

Explainable AI for analyzing cancer outcomes using large-scale genome sequencing data

A multi-tier, explainable AI framework designed to risk-stratify patients and predict overall survival using clinical and genomic covariates is developed and demonstrates that explainable machine learning models can robustly predict survivability and highlight actionable features for oncology dashboards.

P. Nalela · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.